Finished
A Qualitative and Usability Evaluation of Advanced Technologies for Home Upper Limb Neurorehabilitation Post-stroke
NCT06406569 · Tan Tock Seng Hospital · Updated 7 Oct 2026
- What is being tested
- H-Man Robot; ReHandyBot; MyoPanda
- For
- Stroke
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 21 years to 80 years. About 29 people. The full rules are on the registry page.
- Where
- Singapore
- When
- Starts or started 31 July 2024, ends 5 June 2026. Registered 9 May 2024.
- Results
- None posted yet.
In the researchers' words
Due to limited resources such as the low therapist to patient ratio or high costs associated to rehabilitation therapy, providing higher therapy dose to patients after discharge is highly challenging. This often results in non-use of the impaired limb as a result of the decreased therapy dose, causing partial loss of the functional improvements previously gained during early rehabilitation. In this study, the investigators plan to pilot the HomeRehab Gym concept via the deployment of three rehabilitation devices at patients' homes: MyoPanda, H-Man and ReHandyBot.
Sites
- Tan Tock Seng HospitalSingapore, Singapore, Singapore